DNA X, Inc. (SONM): Cost of Revenue
$48.38M
Year ended 2024-12-31
+0.2%
3-year compound annual growth
-10.0%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $48.38M | -34.9% | 2025-03-31, From 2024-01-01 |
| 2023-12-31 | $74.31M | +27.7% | 2025-03-31, From 2023-01-01 |
| 2022-12-31 | $58.20M | +20.9% | 2024-03-27, From 2022-01-01 |
| 2021-12-31 | $48.16M | -1.3% | 2023-03-20, From 2021-01-01 |
| 2020-12-31 | $48.78M | -40.3% | 2022-06-29, From 2020-01-01 |
| 2019-12-31 | $81.74M | -6.7% | 2021-03-18, From 2019-01-01 |
| 2018-12-31 | $87.58M | n/a | 2020-03-27, From 2018-01-01 |